Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal Cancer-Reference-Cited by-同舟云学术

Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal Cancer

Published:2021-07-26 Issue:7 Volume:4 Page:e2117547
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Kehl Kenneth L.¹,Riely Gregory J.²,Lepisto Eva M.¹,Lavery Jessica A.²,Warner Jeremy L.³⁴,LeNoue-Newton Michele L.⁵,Sweeney Shawn M.⁶,Rudolph Julia E.²,Brown Samantha²,Yu Celeste⁷,Bedard Philippe L.⁷⁸,Schrag Deborah¹⁹,Panageas Katherine S.²,Sweeney Shawn¹⁰,Foti Margaret¹⁰,Khotskaya Yekaterina¹⁰,Fiandalo Michael¹⁰,Gross Benjamin¹⁰,Schultz Nikolaus¹⁰,Mastrogiacomo Brooke¹⁰,Sarmardy Mahdi¹⁰,Li Marilyn¹⁰,Resnick Adam¹⁰,Waanders Angela¹⁰,Lilly Jena¹⁰,Carvajal Richard¹⁰,Rabadan Raul¹⁰,Ingham Matthew¹⁰,Hsaio Susan¹⁰,Abraham Jean¹⁰,Brenton James¹⁰,Rueda Oscar¹⁰,Caldas Carlos¹⁰,Valgañón Mikel¹⁰,Silva Dilrini¹⁰,Boursnell Chris¹⁰,Garcia Raquel¹⁰,Rodriguez Ezequiel¹⁰,Nimmervoll Birgit¹⁰,Cerami Ethan¹⁰,Ducar Matthew¹⁰,Kumari Priti¹⁰,Lindeman Neal¹⁰,MacConnaill Laura¹⁰,Orechia John¹⁰,Schrag Deborah¹⁰,Shivdasani Priyanka¹⁰,Van Allen Eliezer¹⁰,Johnson Jason¹⁰,Jänne Pasi¹⁰,Lepisto Eva¹⁰,Hassett Michael¹⁰,Pimentel Sindy¹⁰,Sripakdeevong Parin¹⁰,Janeway Katherine¹⁰,Johnson Jason M.¹⁰,Meyerson Matthew¹⁰,Quinn Daniel¹⁰,Cushing Oya¹⁰,Haigis Kevin¹⁰,Miller Diana¹⁰,Kehl Kenneth¹⁰,Gustav Alexander¹⁰,Tramontano Angela¹⁰,Baquero Simon Arango¹⁰,Bell Jonathan¹⁰,Green Michelle¹⁰,McCall Shannon¹⁰,Datto Michael¹⁰,Calvo Fabien¹⁰,Andre Fabrice¹⁰,Guillaume Meurice¹⁰,Dogan Semih¹⁰,Ludovic Lacroix¹⁰,Scoazec Jean¹⁰,Ardenos Monica¹⁰,Vassal Gilles¹⁰,Michels Stefan¹⁰,Velculescu Victor¹⁰,Baras Alexander¹⁰,Gocke Christopher¹⁰,Brahmer Julie¹⁰,Sawyers Charles¹⁰,Solit David¹⁰,Gardos Stu¹⁰,Berger Mike¹⁰,Ladanyi Marc¹⁰,Riely Gregory¹⁰,Sirintrapun Joseph¹⁰,Caroline Ari¹⁰,Thomas Stacy¹⁰,Zarski Andrew¹⁰,Zehir Ahmet¹⁰,Iasonosa Alexia¹⁰,Philip John¹⁰,Brown Samantha¹⁰,Kung Andrew¹⁰,Kundra Ritika¹⁰,Rudolph Julia¹⁰,Lavery Jessica¹⁰,Rivzi Hira¹⁰,Schwartz Julian¹⁰,McCarthy Caroline¹⁰,Bhuiya Maufur¹⁰,Martin Axel¹⁰,Chu Cynthia¹⁰,DuBois Raymond¹⁰,van de Velde Tony¹⁰,Meijer Geritt¹⁰,Horlings Hugo¹⁰,van Tinteren Harm¹⁰,Lolkema Martijn¹⁰,Nijman Les¹⁰,Bierkens Mariska¹⁰,Hoeve Jelle¹⁰,Voest Emilie¹⁰,Hiemstra Annemieke¹⁰,Sonke Gabe¹⁰,Craenmehr Jacques¹⁰,Hudecek Jan¹⁰,Monkhorst Kim¹⁰,Urba Walter¹⁰,Bernard Brady¹⁰,Piening Brian¹⁰,Bifulco Carlo¹⁰,Tittel Paul¹⁰,Cramer Julie¹⁰,Guinney Justin¹⁰,Yu Thomas¹⁰,Guo Xindi¹⁰,Acebedo Alyssa¹⁰,Gold Philip¹⁰,Bailey Neil¹⁰,Kadri Sabah¹⁰,Segal Jeremy¹⁰,Pankhuri Wanjari¹⁰,Wang Peng¹⁰,George Steinhardt¹⁰,Christine Moung¹⁰,Van't Veer Laura¹⁰,Talevich Eric¹⁰,Wren Amanda¹⁰,Sweet-Cordero Alejandro¹⁰,Turski Michelle¹⁰,Bedard Philippe¹⁰,KamelReid Suzanne¹⁰,Lu Zhibin¹⁰,Pugh Trevor¹⁰,Siu Lillian¹⁰,Watt Stuart¹⁰,Leighl Natasha¹⁰,Yu Celeste¹⁰,Ahmed Lailah¹⁰,Krishna Geeta¹⁰,Virtaenen Carlos¹⁰,Chow Helen¹⁰,Plagianakos Demi¹⁰,Del Rossi Samantha¹⁰,Singaravelan Nitthusha¹⁰,Hakgor Sevan¹⁰,Qazi Nazish¹⁰,Nguyen Alisha¹⁰,Stickle Natalie¹⁰,Stricker Thomas¹⁰,Micheel Christine¹⁰,Anderson Ingrid¹⁰,Jones Leigh¹⁰,Wang Lucy¹⁰,Lovly Christine¹⁰,LeNoue Newton Michele¹⁰,Park Ben¹⁰,Warner Jeremy¹⁰,Fabbri Daniel¹⁰,Coco Joseph¹⁰,Ye Chen¹⁰,Chaugai Sandip¹⁰,Mishra Sanjay¹⁰,Yang Yuanchu James¹⁰,Wen Li¹⁰,Dienstmann Rodrigo¹⁰,Aguilar Izquierdo Susana¹⁰,Viaplana Donato Cristina¹⁰,Mancuso Francesco¹⁰,Topaloglu Umit¹⁰,Liu Liang¹⁰,Guan Meijian¹⁰,Zhang Wei¹⁰,Jin Guangxu¹⁰,Knight James¹⁰,D'Eletto Michael¹⁰,Ormay E. Zeynep¹⁰,Mane Shrikant¹⁰,Bilguvar Kaya¹⁰,Zenta Walther¹⁰,Dykas Daniel¹⁰,

Affiliation:

1. Department of Medical Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

3. Department of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

4. Department of Biomedical Informatics, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

5. Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

6. American Association for Cancer Research, Philadelphia, Pennsylvania

7. Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre/University Health Network, Toronto, Ontario, Canada

8. Department of Medicine, University of Toronto, Toronto, Ontario, Canada

9. Associate Editor, JAMA

10. for the American Association of Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) Consortium

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2782339/kehl_2021_oi_210522_1626794904.01114.pdf

Reference33 articles.

1. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).;Eisenhauer;Eur J Cancer,2009

2. Status update on data required to build a learning health system.;Bertagnolli;J Clin Oncol,2020

3. AACR Project GENIE: powering precision medicine through an international consortium.;AACR Project GENIE Consortium;Cancer Discov,2017

4. Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non–small-cell lung cancer.;Blumenthal;Ann Oncol,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry;Cancer Research Communications;2024-02-20

2. Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study;Journal of Cancer Research and Clinical Oncology;2024-02-12

3. Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors;Current Oncology;2024-01-03

4. Real-World Comparative Outcomes of Egfr-Tkis for First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer;2024

5. Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and Solutions;Value in Health;2023-11